https://www.live-feeds.com/feed/glp-1-injections-recalled-nationwide-over-sterility-concernsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/glp-1-injections-recalled-nationwide-over-sterility-concernshttps://www.live-feeds.com/feed/glp-1-injections-recalled-nationwide-over-sterility-concerns#u151991Sat, 24 Oct 2026 12:56:25 +0000Federal regulators have initiated a nationwide recall of specific compounded GLP-1 and NAD+ injectable medications due to a lack of assurance of sterility. Apothecary Pharma issued the recall for the affected products, which include tirzepatide weight-loss injections distributed across the United States. The Food and Drug Administration raised the risk level of the recall to the second-highest category, known as Class II. Patients using these specific compounded weight-loss treatments are urged to check product details to determine if their medication is safe, following warnings from health au